Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

• 主要な著者: Yusri Taha (著者), Hayley Wardle (著者), Adam B. Evans (著者), Ewan R. Hunter (著者), Helen Marr (著者), Wendy Osborne (著者), Matthew Bashton (著者), Darren Smith (著者), Shirelle Burton-Fanning (著者), Matthias L. Schmid (著者), Christopher J. A. Duncan (著者)
• フォーマット: 図書
• 出版事項: BMC, 2021-12-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Background There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at increased risk of persistent infection. This challenging clinical scenario is associated with adverse patient out...